Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MW05 vs PEG-rhG-CSF in Chemotherapy-Induced Neutropenia
NCT04554056Phase 3Completed
- Sponsor
- Mabwell
- Start
- Sep 2020
- Primary completion
- Aug 2022
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of rHSA-GCSF in chemotherapy-induced neutropenia (CIN), sponsored by Mabwell. Started Sep 2020; status: completed.
02
Drugs
rHSA-GCSF
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT04554056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04554056.